Here are what the editors at HealthDay consider to be the most important developments in Surgery for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Robotically Assisted Devices Not Approved for Cancer Surgery
THURSDAY, Feb. 28, 2019 (HealthDay News) — The use of robotically assisted surgical devices for breast removal and other cancer-related surgeries is not approved by the U.S. Food and Drug Administration because there is no proof of its safety or effectiveness in such cases, the agency says in a warning to doctors and patients.
Risk Factors ID’d for Site Infection After Orthopedic Surgery in Seniors
THURSDAY, Feb. 28, 2019 (HealthDay News) — Five risk factors are independently associated with surgical site infection among geriatric patients undergoing elective orthopedic surgery, according to a study published online Feb. 20 in the International Wound Journal.
Intervention Can Reduce Racial Differences in Lung Cancer Care
THURSDAY, Feb. 28, 2019 (HealthDay News) — An intervention that includes race-specific feedback and real-time electronic warnings can reduce racial differences in care for early-stage lung cancer, according to a study published online Feb. 4 in Cancer Medicine.
Lymphadenectomy Does Not Up Survival in Advanced Ovarian Cancer
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — For patients with advanced ovarian cancer who have undergone intra-abdominal macroscopically complete resection and have clinically negative lymph nodes, lymphadenectomy is not associated with longer overall or progression-free survival, according to a study published in the Feb. 28 issue of the New England Journal of Medicine.
Rate of Opioid Rx Stable After Pediatric Outpatient Surgery
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — From 2013 to 2017, the rate of receiving a take-home opioid prescription remained stable after pediatric outpatient surgery as did the dose prescribed, but the maximum take-home dose declined, according to a study recently published in Pain Medicine.
Kidney Disease Affects Revascularization Outcomes
WEDNESDAY, Feb. 27, 2019 (HealthDay News) — The presence of comorbid chronic kidney disease (CKD) negatively impacts myocardial revascularization outcomes in patients with type 2 diabetes mellitus (T2DM), according to a study published in the Feb. 5 issue of the Journal of the American College of Cardiology.
Overlapping Surgery Appears Safe for Common Procedures